News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mapi Collaborates With YPrime To Accelerate The Deployment Of eCOA Solutions



7/17/2017 9:00:00 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

LONDON, July 17, 2017 /PRNewswire/ -- Mapi, the original developer of Linguistic Validation and most trusted provider of Clinical Outcome Assessments collaborates with YPrime, the leading clinical research technology provider, to streamline the deployment of validated Assessments migrated onto YPrime's eCOA platform.

Mapi has been the leading authority in linguistic validation and cross-cultural adaptation for over a quarter of a century, Mapi pioneered the key methodologies of adapting COAs for inclusion in multinational clinical trials and continues to do so better than anyone else. No other provider in the industry offers the depth of experience and expertise that Mapi provides.

Mapi Language services and YPrime are leveraging cloud level integrations between technology platforms to establish a seamless operational interface between Mapi's ISO 17100 certified process and YPrime's eCOA platform facilitating Linguistic Validations and direct screenshot reviews enabling faster turnaround time and higher quality assurance of migrated instruments.

The collaboration will also deliver integration for Mapi to directly develop and validate eCOAs on YPrime's platform eliminating the manual versioning and migrated questionnaire processes for new 'born on eCOA' questionnaires. The cloud facilitated integration process improves migration integrity of paper originated COAs. This expands Mapi's and YPrime's offering to support our mutual clients with simultaneous multi-lingual development of eCOAs directly on Y-Prime's platform.

"Working with MAPI is part of YPrime's strategy to simplify access, and expedite start-up timelines to eCOA implementation for research organizations across the industry," said Mark Maietta, Chief Commercial Officer of YPrime. "We are thrilled about the opportunity to align our advanced platform with the largest provider of Patient-Centered Outcome instruments in this initiative. With established benefits in user experience, data quality and regulatory acceptance of eCOA solutions, I am confident this alliance will accelerate the already-burgeoning eCOA market adoption."

The new process will reduce the Linguistic Validation cycle and accelerate deployment enabling quicker 'first patient in' timelines. Additionally, the alliance enables real time collaboration reducing review and correction cycles. The entire process tightly follows Mapi's ISO 17100 Certification and offers direct multi-language simultaneous development of validated eCOAs on YPrime's eCOA platform.

"This collaboration demonstrates Mapi's commitment to transparency, quality and diligence in supporting our clients and YPrime's innovation in developing industry integrated platforms breaking the collaborative service barrier across COA licensing, Language Services and eCOA platform providers." Commented Elan Josielewski, Mapi's VP of Corporate Strategy and Global Marketing. 

Benefits to our customers:

  • eCOAs developed and validated directly on the platform used to collect the outcome data.
  • Assurance that Linguistic Validations are completed seamlessly by the industry's most experienced Language Services team and the industry's most trusted experts.
  • eCOA screens are reviewed and certified without the need to email screenshot files

About Mapi Language Services:
Mapi Language Services is the worldwide leader in medical translation and linguistic validation of COAs. Mapi Language Services' experience represents more than 40,000 linguistically validated versions of over 2,500 Questionnaires into 170 languages.

About YPrime
For more than a decade, YPrime has specialized in providing technology and services that enable new and better ways of clinical trial information management. We design the most configurable software to meet study-specific requirements, and support the needs of sponsors, patients and sites throughout a clinical trial. YPrime's consulting services help clients use clinical systems efficiently and make informed decisions through the power of their own data.

Press contact: Media@mapigroup.com

Technology that enables and automates the research process is equally as important as the underlying science in the success of clinical trials. Sponsors and CROs know they can rely on YPrime for IRT, eCOA and a host of clinical data services to simplify increasingly difficult work. YPrimes forward-looking software solutions give you both the tools you need and the data when you want it.

 

Mapi Group

 

View original content with multimedia:http://www.prnewswire.com/news-releases/mapi-collaborates-with-yprime-to-accelerate-the-deployment-of-ecoa-solutions-300488597.html

SOURCE Mapi


Read at BioSpace.com


comments powered by Disqus
YPrime
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES